Algeria’s first bioequivalence study for a drug
Yesterday, Sunday, in Algiers, the Algerian bioequivalence center “Equival Biocenter” presented its first bioequivalence study to demonstrate the therapeutic efficacy of a generic antibiotic produced by the state-owned pharmaceutical group “Saidal”. Read more…